1887

Abstract

Kaposi’s sarcoma-associated herpesvirus (KSHV) encodes four viral interferon regulatory factors (vIRF-1–4). We investigated the mechanism and consequences of vIRF-2-mediated inhibition of interferon-response element signalling following type I interferon (IFN) induction. Western blot and electrophoretic mobility-shift assays identified the interferon-stimulated gene factor-3 (ISGF-3) components STAT1 and IRF-9 as the proximal targets of vIRF-2 activity. The biological significance of vIRF-2 inhibition of ISGF-3 was demonstrated by vIRF-2-mediated rescue of the replication of the IFN-sensitive virus encephalomyocarditis virus. This study provides both a mechanism and evidence for KSHV vIRF-2-mediated suppression of the consequences of type 1 IFN-induced signalling.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.034322-0
2011-10-01
2019-12-16
Loading full text...

Full text loading...

/deliver/fulltext/jgv/92/10/2394.html?itemId=/content/journal/jgv/10.1099/vir.0.034322-0&mimeType=html&fmt=ahah

References

  1. Aresté C., Blackbourn D. J.. ( 2009; ). Modulation of the immune system by Kaposi’s sarcoma-associated herpesvirus. . Trends Microbiol 17:, 119–129. [CrossRef] [PubMed]
    [Google Scholar]
  2. Aresté C., Mutocheluh M., Blackbourn D. J.. ( 2009; ). Identification of caspase-mediated decay of interferon regulatory factor-3, exploited by a Kaposi sarcoma-associated herpesvirus immunoregulatory protein. . J Biol Chem 284:, 23272–23285. [CrossRef] [PubMed]
    [Google Scholar]
  3. Bouvard V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F., Benbrahim-Tallaa L., Guha N., Freeman C. et al. & other authors ( 2009; ). A review of human carcinogens – part B: biological agents. . Lancet Oncol 10:, 321–322. [CrossRef] [PubMed]
    [Google Scholar]
  4. Burýsek L., Pitha P. M.. ( 2001; ). Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated protein kinase. . J Virol 75:, 2345–2352. [CrossRef] [PubMed]
    [Google Scholar]
  5. Burysek L., Yeow W. S., Pitha P. M.. ( 1999; ). Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2). . J Hum Virol 2:, 19–32.[PubMed]
    [Google Scholar]
  6. Chang Y., Cesarman E., Pessin M. S., Lee F., Culpepper J., Knowles D. M., Moore P. S.. ( 1994; ). Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. . Science 266:, 1865–1869. [CrossRef] [PubMed]
    [Google Scholar]
  7. Chatterjee M., Osborne J., Bestetti G., Chang Y., Moore P. S.. ( 2002; ). Viral IL-6-induced cell proliferation and immune evasion of interferon activity. . Science 298:, 1432–1435. [CrossRef] [PubMed]
    [Google Scholar]
  8. Cunningham C., Barnard S., Blackbourn D. J., Davison A. J.. ( 2003; ). Transcription mapping of human herpesvirus 8 genes encoding viral interferon regulatory factors. . J Gen Virol 84:, 1471–1483. [CrossRef] [PubMed]
    [Google Scholar]
  9. Fuld S., Cunningham C., Klucher K., Davison A. J., Blackbourn D. J.. ( 2006; ). Inhibition of interferon signaling by the Kaposi’s sarcoma-associated herpesvirus full-length viral interferon regulatory factor 2 protein. . J Virol 80:, 3092–3097. [CrossRef] [PubMed]
    [Google Scholar]
  10. Gao S. J., Boshoff C., Jayachandra S., Weiss R. A., Chang Y., Moore P. S.. ( 1997; ). KSHV ORF K9 (vIRF) is an oncogene which inhibits the interferon signaling pathway. . Oncogene 15:, 1979–1985. [CrossRef] [PubMed]
    [Google Scholar]
  11. Gauzzi M. C., Velazquez L., McKendry R., Mogensen K. E., Fellous M., Pellegrini S.. ( 1996; ). Interferon-α-dependent activation of Tyk2 requires phosphorylation of positive regulatory tyrosines by another kinase. . J Biol Chem 271:, 20494–20500. [CrossRef] [PubMed]
    [Google Scholar]
  12. Krishnan H. H., Naranatt P. P., Smith M. S., Zeng L., Bloomer C., Chandran B.. ( 2004; ). Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi’s sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression. . J Virol 78:, 3601–3620. [CrossRef] [PubMed]
    [Google Scholar]
  13. Li M., Damania B., Alvarez X., Ogryzko V., Ozato K., Jung J. U.. ( 2000; ). Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor. . Mol Cell Biol 20:, 8254–8263. [CrossRef] [PubMed]
    [Google Scholar]
  14. Lubyova B., Pitha P. M.. ( 2000; ). Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors. . J Virol 74:, 8194–8201. [CrossRef] [PubMed]
    [Google Scholar]
  15. Morrison J. M., Racaniello V. R.. ( 2009; ). Proteinase 2Apro is essential for enterovirus replication in type I interferon-treated cells. . J Virol 83:, 4412–4422. [CrossRef] [PubMed]
    [Google Scholar]
  16. Randall R. E., Goodbourn S.. ( 2008; ). Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. . J Gen Virol 89:, 1–47. [CrossRef] [PubMed]
    [Google Scholar]
  17. Rezaee S. A., Cunningham C., Davison A. J., Blackbourn D. J.. ( 2006; ). Kaposi’s sarcoma-associated herpesvirus immune modulation: an overview. . J Gen Virol 87:, 1781–1804. [CrossRef] [PubMed]
    [Google Scholar]
  18. Schmidt K., Wies E., Neipel F.. ( 2011; ). Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 3 inhibits gamma interferon and major histocompatibility complex class II expression. . J Virol 85:, 4530–4537. [CrossRef] [PubMed]
    [Google Scholar]
  19. Shin Y. C., Nakamura H., Liang X., Feng P., Chang H., Kowalik T. F., Jung J. U.. ( 2006; ). Inhibition of the ATM/p53 signal transduction pathway by Kaposi’s sarcoma-associated herpesvirus interferon regulatory factor 1. . J Virol 80:, 2257–2266. [CrossRef] [PubMed]
    [Google Scholar]
  20. Wies E., Hahn A. S., Schmidt K., Viebahn C., Rohland N., Lux A., Schellhorn T., Holzer A., Jung J. U., Neipel F.. ( 2009; ). The Kaposi’s sarcoma-associated herpesvirus-encoded vIRF-3 inhibits cellular IRF-5. . J Biol Chem 284:, 8525–8538. [CrossRef] [PubMed]
    [Google Scholar]
  21. Zimring J. C., Goodbourn S., Offermann M. K.. ( 1998; ). Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription. . J Virol 72:, 701–707.[PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.034322-0
Loading
/content/journal/jgv/10.1099/vir.0.034322-0
Loading

Data & Media loading...

Supplements

vol. , part 10, pp. 2394–2398

Quantification of the pSTAT1 and IRF-9 immunoblots.

[ PDF file] (164 KB)



PDF

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error